About Refeyn
Refeyn is a company based in Oxford (United Kingdom) founded in 2018 by Philipp Kukura.. Refeyn has raised $32.92 million across 5 funding rounds from investors including University of Oxford, Oxford Technology and Northpond Ventures. Refeyn offers products and services including TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System. Refeyn operates in a competitive market with competitors including 908 Devices, Advion, Impedimed, Zeteo Tech and Rigaku, among others.
- Headquarter Oxford, United Kingdom
- Founders Philipp Kukura
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Refeyn Ltd
- Date of Incorporation 27 Apr, 2018
- Jurisdiction OXFORD, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.92 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
University of Oxford
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Refeyn
Refeyn offers a comprehensive portfolio of products and services, including TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Measures molecular mass of biomolecules with speed and accuracy.
Analyzes AAV vectors for development and manufacturing processes.
Characterizes viral particles for size, purity, and stability.
Supports mass photometry for enhanced sample handling.
Unlock access to complete
Software Development Team
12 people
Product Management Team
7 people
Sales and Marketing
6 people
Leadership Team
5 people
Operations Team
2 people
Finance and Accounting
2 people
Human Resources and Administration
2 people
Logistics Team
2 people
Unlock access to complete
Funding Insights of Refeyn
Refeyn has successfully raised a total of $32.92M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(26 Jun 2018)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2022 | Amount | Series B - Refeyn | Valuation | Northpond Ventures | |
| Nov, 2020 | Amount | Series A - Refeyn | Valuation |
investors |
|
| Mar, 2019 | Amount | Series A - Refeyn | Valuation | Oxford Science Enterprises |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Refeyn
Refeyn has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Oxford, Oxford Technology and Northpond Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Founded Year | Domain | Location | |
|
Investment management services for science ventures are provided in Oxford.
|
Founded Year | Domain | Location | |
|
Horizons Ventures is focused on investing in deep science and technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Refeyn
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Refeyn
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Refeyn Comparisons
Competitors of Refeyn
Refeyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 908 Devices, Advion, Impedimed, Zeteo Tech and Rigaku, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld chemical detection devices are manufactured using mass spectrometry.
|
|
| domain | founded_year | HQ Location |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| domain | founded_year | HQ Location |
Technologies for non-invasive fluid status assessment and monitoring are developed.
|
|
| domain | founded_year | HQ Location |
Biological mass spectrometers are manufactured for airborne microbe detection.
|
|
| domain | founded_year | HQ Location |
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Refeyn
Frequently Asked Questions about Refeyn
When was Refeyn founded?
Refeyn was founded in 2018.
Where is Refeyn located?
Refeyn is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Refeyn a funded company?
Refeyn is a funded company, having raised a total of $32.92M across 5 funding rounds to date. The company's 1st funding round was a Series A of $3.4M, raised on Jun 26, 2018.
What does Refeyn do?
Refeyn was founded in 2018 in Oxford, United Kingdom, within the biotechnology sector. Technology for assessing single molecular mass is created by the company, focusing on biomolecular analysis. Operations center on the development of mass photometry tools, with the Refeyn product utilizing single-molecule light scattering to identify properties such as size and concentration of biomolecules in solution.
Who are the top competitors of Refeyn?
Refeyn's top competitors include 908 Devices, Impedimed and Advion.
What products or services does Refeyn offer?
Refeyn offers TwoMP, SamuxMP, KariTroMP, and MassFluidix HC System.
Who are Refeyn's investors?
Refeyn has 7 investors. Key investors include University of Oxford, Oxford Technology, Northpond Ventures, Oxford Science Enterprises, and Foresight Group.
What is Refeyn's valuation?
The valuation of Refeyn is $71.2M as of Nov 2020.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.